Literature DB >> 8733758

Anorexia induced by activators of the signal transducer gp 130.

C R Plata-Salamán1.   

Abstract

Cytokines [interleukin (IL-1, chemokines/intercrines, interferon, tumor necrosis factor-alpha (TNF-alpha)] induce anorexia when administered intracerebroventricularly (i.c.v.) at estimated pathophysiological concentrations. Here, the effects of the i.c.v. microinfusion (1.0, 20 and 100 ng) of activators of glycoprotein (gp) 130, a common signal transducer among receptors for members of the IL-6 subfamily [IL-6, IL-11, ciliary neurotrophic factor, leukemia inhibitory factor (LIF), oncostatin M (OSM)], on short-term feeding in rats were investigated. Several members of the IL-6 subfamily induced anorexia, IL-11 was the most potent, LIF the most effective, and OSM had no effect. The results suggest that IL-6 subfamily members act centrally to decrease feeding and this effect may participate in the anorexia which frequently accompanies pathological processes. This action could interact with the anorexigenic effect of other cytokines released during disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733758     DOI: 10.1097/00001756-199602290-00038

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

2.  Plasma levels of interleukin-6 and interleukin-18 after an acute physical exercise: relation with post-exercise energy intake in twins.

Authors:  C Almada; L R Cataldo; S V Smalley; E Diaz; A Serrano; M I Hodgson; J L Santos
Journal:  J Physiol Biochem       Date:  2012-07-19       Impact factor: 4.158

3.  Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.

Authors:  G Senaldi; B C Varnum; U Sarmiento; C Starnes; J Lile; S Scully; J Guo; G Elliott; J McNinch; C L Shaklee; D Freeman; F Manu; W S Simonet; T Boone; M S Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 4.  Neuropeptides in the pathophysiology and treatment of cachexia.

Authors:  Stephanie M Krasnow; Daniel L Marks
Journal:  Curr Opin Support Palliat Care       Date:  2010-12       Impact factor: 2.302

5.  A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain.

Authors:  Denis G Baskin; Francis Kim; Richard W Gelling; Brian J Russell; Michael W Schwartz; Gregory J Morton; Hyagriv N Simhan; Daniel H Moralejo; James E Blevins
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

6.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; XinXia Zhu; Darren D Bowe; Ayesha K Batra; Theodore P Braun; Daniel L Marks
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

7.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

8.  Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation.

Authors:  Jarrad M Scarlett; Xinxia Zhu; Pablo J Enriori; Darren D Bowe; Ayesha K Batra; Peter R Levasseur; Wilmon F Grant; Michael M Meguid; Michael A Cowley; Daniel L Marks
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

9.  Lipopolysacharide Rapidly and Completely Suppresses AgRP Neuron-Mediated Food Intake in Male Mice.

Authors:  Yang Liu; Ying Huang; Tiemin Liu; Hua Wu; Huxing Cui; Laurent Gautron
Journal:  Endocrinology       Date:  2016-04-25       Impact factor: 4.736

10.  Pathophysiology and treatment of inflammatory anorexia in chronic disease.

Authors:  Theodore P Braun; Daniel L Marks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.